Mannkind Corporation - Company & Market Research Reports

MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product is AFREZZA, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. MannKind Corporation has license and collaboration agreement with Sanofi-Aventis Deutschland GmbH for the development of AFREZZA. The company was founded in 1991 and is headquartered in Valencia, California.


Diabetes Therapeutics Market by Product [Injectables] - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Thumbnail Image

Diabetes Therapeutics Market by Product [Injectables] - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report
  • 170 Pages
From
Cardiovascular Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Cardiovascular Disorders Drug Development Pipeline Review, 2017

  • Report
  • 432 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 980 Pages
From
Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2017

  • Report
  • 246 Pages
From
Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments - Product Thumbnail Image

Multiple Myeloma Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments

  • Report
  • 117 Pages
From
Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments - Product Thumbnail Image

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

  • Report
  • 119 Pages
From
Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026

  • Report
  • 359 Pages
From
Global Diabetes Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Diabetes Market Research and Forecast, 2018-2023

  • Report
From
Afrezza 2016 U.S Promotional Report - Product Thumbnail Image

Afrezza 2016 U.S Promotional Report

  • Report
  • 21 Pages
From
Global Diabetic Therapeutic Market 2017-2021 - Product Thumbnail Image

Global Diabetic Therapeutic Market 2017-2021

  • Report
  • 167 Pages
From
Global Metabolic Disorders Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Metabolic Disorders Therapeutics Market 2016-2020

  • Report
  • 163 Pages
From
Diabetes Drug Therapy market: Asia-Pacific Industry Analysis, Trends, Market Size and Forecasts up to 2023 - Product Thumbnail Image

Diabetes Drug Therapy market: Asia-Pacific Industry Analysis, Trends, Market Size and Forecasts up to 2023

  • Report
  • 100 Pages
From
Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations - Product Thumbnail Image

Type 1 Diabetes Mellitus Therapeutics in Major Developed Markets to 2021 - Innovative and Diversified Pipeline to Drive Market Growth Despite Patent Expirations

  • Report
  • 160 Pages
From
Global Diabetes Drug Market & Pipeline Insight 2015 - Product Thumbnail Image

Global Diabetes Drug Market & Pipeline Insight 2015

  • Drug Pipelines
  • 1100 Pages
From
Global Endocrinology Drugs Market 2016-2020 - Product Thumbnail Image

Global Endocrinology Drugs Market 2016-2020

  • Report
  • 118 Pages
From
Global Type 2 Diabetes Market 2016-2020 - Product Thumbnail Image

Global Type 2 Diabetes Market 2016-2020

  • Report
  • 122 Pages
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Report
  • 1109 Pages
From
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2018

  • Report
  • 576 Pages
From
Type 2 Diabetes - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2017

  • Report
  • 1126 Pages
From
Loading Indicator
adroll